Skip to main content
OpenTrials

Clinical trial condition

Thalassemia

Explore clinical trials studying Thalassemia. Study availability and eligibility vary by location and protocol.

105 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Thalassemia trial results

Not yet recruiting

A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)

NCT07579949

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations
  • Foshan First People's Hospital Foshan, Guangdong, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Maoming People's Hospital Maoming, Guangdong, China
  • Liuzhou People's Hospital Liuzhou, Guangxi, China
View Trial Details
Enrolling by invitation

A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study

NCT05777993

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations
  • McMaster Centre for Transfusion Medicine McMaster University Hamilton, Ontario, Canada
  • Tohoku University Hospital Sendai, Miyagi, Japan
  • Kyoto Katsura Hospital Kyoto, Japan
  • Toho University - Omori Medical Center Ōta-ku, Japan
View all 23 locations
View Trial Details
Enrolling by invitation

A Long-term Follow-up Study in Participants Who Received CTX001

NCT04208529

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago - Hematology Chicago, Illinois, United States
  • Herbert Irving Pavilion - Hematology New York, United States
  • New York Presbyterian Hospital - Morgan Stanley Children's Hospital New York, United States
View all 20 locations
View Trial Details
Active, not recruiting

CINC424A2X01B Rollover Protocol

NCT02386800

Conditions
Acute Myeloid Leukemia, Anemia, Anemia, Hemolytic, +31 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Wooloongabba, Queensland, Australia
  • Novartis Investigative Site Bedford Park, South Australia, Australia
View all 97 locations
View Trial Details
Active, not recruiting

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

NCT05356195

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • TriStar Medical Group Children's Specialists - Pediatric Oncology Nashville, Tennessee, United States
  • Hospital for Sick Children - Hematology Toronto, Canada
  • University Hospital Dusseldorf - Department of Pediatric Oncology, Hematology and Clinical Immunology Düsseldorf, Germany
  • IRCSS Ospedale Pediatrico Bambino Gesu - Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica Rome, Italy
View Trial Details
Active, not recruiting

A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia

NCT03692052

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University Health Network (Toronto General Hospital) Toronto, Ontario, Canada
  • Imperial College Healthcare NHS Trust (Hammersmith Hospital) London, United Kingdom
View Trial Details

Related conditions